2m 2m 2m 2m 2m 2m 2m
TRISALS LIFE SCI (TLSI)
NASDAQ
$4.13-$0.11 (-2.48%)
Price as of Jul 14, 2026 6:37 AM EDT- $259.8MMarket Cap
- -15.06%1-Year Change
- Medical DevicesIndustry
TRISALS LIFE SCI (TLSI)
$4.13-$0.11 (-2.48%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FIRST LIGHT ASSET MANAGEMENT, LLC | 13.37% | 5.1M | +5.1M (+100.00%) | Mar 31, 2026 |
AWM INVESTMENT COMPANY, INC. | 5.48% | 2.1M | +835,325 (+40.18%) | Mar 31, 2026 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 5.46% | 2.1M | 0 (0.00%) | Mar 31, 2026 |
VANGUARD GROUP INC | 4.04% | 1.5M | +371,132 (+24.25%) | Dec 31, 2025 |
BLACKROCK, INC. | 3.96% | 1.5M | -34,789 (-2.32%) | Mar 31, 2026 |
WASATCH ADVISORS LP | 3.79% | 1.4M | +1.4M (+100.00%) | Mar 31, 2026 |
N/A | 3.55% | 1.3M | +1.3M (+100.00%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
WASATCH FUNDS TRUST | 3.76% | 1.4M | +1.4M (+100.00%) | Mar 31, 2026 |
VANGUARD INDEX FUNDS | 3.39% | 1.3M | +194,415 (+15.12%) | Mar 31, 2026 |
iSHARES TRUST | 2.54% | 963,680 | 0 (0.00%) | Apr 30, 2026 |
FIDELITY CONCORD STREET TRUST | 0.90% | 342,896 | 0 (0.00%) | Apr 30, 2026 |
FIDELITY SALEM STREET TRUST | 0.72% | 274,589 | +242,881 (+88.45%) | Apr 30, 2026 |
ROYCE FUND | 0.53% | 200,000 | +200,000 (+100.00%) | Mar 31, 2026 |
VANGUARD SCOTTSDALE FUNDS | 0.46% | 175,775 | +68,858 (+39.17%) | Feb 28, 2026 |
Current Ownership Distribution
- Institutions56.1M (56.11%)
- Insiders25.3M (25.32%)
- Mutual Funds18.6M (18.57%)
- Other0 (0.00%)
Insider Transactions
- 25.32% (25.3M)Current InsiderOwnership (%, shares)
- 3Number of InsiderBuying (last 12 months)
- $4.1MAmount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $12.1MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Patience David Chief Financial Officer | In Kind | Jul 01, 2026 | $65,339.00 | 14,650 | $4.46 | 261,107 |
Marshak Richard Chief Commercial Officer | Award | Jun 30, 2026 | $2,171.07 | 561 | $3.87 | 128,319 |
Szela Mary T CEO and President | Award | Jun 30, 2026 | $15,441.30 | 3,990 | $3.87 | 1.1M |
Marshall Richard Henry Chief Medical Officer | Award | Jun 29, 2026 | $0.00 | 120,000 | $0.00 | 253,000 |
Marshall Richard Henry Chief Medical Officer | Award | Jun 29, 2026 | $0.00 | 60,000 | $0.00 | 90,000 |
Szela Mary T CEO and President | Sell | Mar 17, 2026 | $61,384.40 | 15,944 | $3.85 | 752,987 |
Devlin Jodi Chief of Clinical Operations | Sell | Mar 16, 2026 | $1,124.76 | 273 | $4.12 | 97,364 |
Marshak Richard Chief Commercial Officer | Sell | Mar 16, 2026 | $1,726.28 | 419 | $4.12 | 110,397 |
Cox Bryan F. Chief of Research | Sell | Mar 16, 2026 | $2,385.48 | 579 | $4.12 | 163,415 |
Stevens Jennifer Chief Regulatory Officer | Sell | Mar 16, 2026 | $3,188.88 | 774 | $4.12 | 124,110 |
Devlin Jodi Chief of Clinical Operations | Sell | Mar 12, 2026 | $7,247.48 | 1,772 | $4.09 | 97,637 |
Marshak Richard Chief Commercial Officer | Sell | Mar 12, 2026 | $6,499.01 | 1,589 | $4.09 | 110,816 |
Cox Bryan F. Chief of Research | Sell | Mar 12, 2026 | $6,000.03 | 1,467 | $4.09 | 163,994 |
Stevens Jennifer Chief Regulatory Officer | Sell | Mar 12, 2026 | $6,347.68 | 1,552 | $4.09 | 124,884 |
Devlin Jodi Chief of Clinical Operations | Sell | Mar 11, 2026 | $4,799.06 | 1,162 | $4.13 | 99,409 |
Szela Mary T CEO and President | Sell | Mar 11, 2026 | $17,998.54 | 4,358 | $4.13 | 768,931 |
Cox Bryan F. Chief of Research | Sell | Mar 11, 2026 | $4,699.94 | 1,138 | $4.13 | 165,461 |
Marshak Richard Chief Commercial Officer | Sell | Mar 11, 2026 | $5,984.37 | 1,449 | $4.13 | 112,405 |
Stevens Jennifer Chief Regulatory Officer | Sell | Mar 11, 2026 | $4,972.52 | 1,204 | $4.13 | 126,436 |
Gordon Gary B. | Buy | Feb 23, 2026 | $39,999.60 | 9,756 | $4.10 | 9,756 |
Szela Mary T CEO and President | Buy | Feb 23, 2026 | $124,996.70 | 30,487 | $4.10 | 773,289 |
Patience David Chief Financial Officer | Buy | Feb 23, 2026 | $14,993.70 | 3,657 | $4.10 | 268,657 |
Stansky Michael P | Award | Feb 04, 2026 | $0.00 | 92,537 | $0.00 | 92,537 |
Marshak Richard Chief Commercial Officer | Award | Dec 31, 2025 | $1,966.62 | 449 | $4.38 | 131,758 |
Szela Mary T CEO and President | Award | Dec 31, 2025 | $9,198.00 | 2,100 | $4.38 | 1.0M |
Patience David Chief Financial Officer | Award | Aug 28, 2025 | $0.00 | 248,899 | $0.00 | 538,899 |
Patience David Chief Financial Officer | Award | Aug 14, 2025 | $0.00 | 290,000 | $0.00 | 290,000 |
Patience David Chief Financial Officer | Award | Aug 14, 2025 | $0.00 | 200,000 | $0.00 | 200,000 |
MATLIN DAVID J | Conversion | Jul 31, 2025 | $0.00 | 100,000 | $0.00 | 0 |
MATLIN DAVID J | Conversion | Jul 31, 2025 | $0.00 | 330,000 | $0.00 | 1.3M |